Skip to Content
MilliporeSigma

Skip To

563927

Sigma-Aldrich

4-Fluorobenzylmagnesium chloride

0.25 M in THF

Synonym(s):

p-Fluorobenzylmagnesium chloride, p-Fluorophenylmethylmagnesium chloride, Chloro(p-fluorobenzyl)magnesium

Sign Into View Organizational & Contract Pricing

Select a Size

25 MG
CA$164.00

CA$164.00


Please contact Customer Service for Availability

Request a Bulk Order

Select a Size

Change View
25 MG
CA$164.00

About This Item

Linear Formula:
FC6H4CH2MgCl
CAS Number:
Molecular Weight:
168.88
MDL number:
UNSPSC Code:
12352103
PubChem Substance ID:
NACRES:
NA.22

CA$164.00


Please contact Customer Service for Availability

Request a Bulk Order
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

reaction suitability

reaction type: Grignard Reaction

Quality Level

concentration

0.25 M in THF

bp

65 °C (lit.)

density

0.910 g/mL at 25 °C (lit.)

functional group

fluoro

storage temp.

2-8°C

SMILES string

Fc1ccc(C[Mg]Cl)cc1

InChI

1S/C7H6F.ClH.Mg/c1-6-2-4-7(8)5-3-6;;/h2-5H,1H2;1H;/q;;+1/p-1

InChI key

PQDGQUPDDGUKLP-UHFFFAOYSA-M

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
328820419532225916
reaction suitability

reaction type: Grignard Reaction

reaction suitability

reaction type: Grignard Reaction

reaction suitability

reaction type: Grignard Reaction

reaction suitability

reaction type: Grignard Reaction

concentration

0.25 M in THF

concentration

1.0 M in THF

concentration

0.5 M in THF

concentration

2.0 M in THF

Quality Level

100

Quality Level

100

Quality Level

100

Quality Level

100

density

0.910 g/mL at 25 °C (lit.)

density

1.021 g/mL at 25 °C

density

0.915 g/mL at 25 °C

density

1.031 g/mL at 25 °C

storage temp.

2-8°C

storage temp.

-

storage temp.

-

storage temp.

-

bp

65 °C (lit.)

bp

-

bp

65-67 °C

bp

-

Legal Information

Product of Rieke Metals, Inc.
Rieke is a registered trademark of Rieke Metals, Inc.

Signal Word

Danger

Hazard Statements

Hazard Classifications

Acute Tox. 4 Oral - Carc. 2 - Flam. Liq. 2 - Skin Corr. 1B - STOT SE 3

Target Organs

Respiratory system

Supplementary Hazards

Storage Class Code

3 - Flammable liquids

WGK

WGK 3

Flash Point(F)

<1.4 °F - closed cup

Flash Point(C)

< -17 °C - closed cup

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

A P Lea et al.
Drugs, 51(5), 846-864 (1996-05-01)
Stavudine is a nucleoside analogue which undergoes intracellular phosphorylation to its active metabolite, stavudine-5'-triphosphate. At clinically relevant concentrations, the active metabolite restricts HIV replication by inhibiting the inclusion of thymidine-5'-triphosphate into proviral DNA by HIV reverse transcriptase, and/or by causing
Dam Anh Tran et al.
Sexually transmitted infections, 90(7), 538-544 (2014-03-13)
This study examines the proportions and causes of virological failure after one year of antiretroviral therapy (ART) among people living with HIV (PLHIV) in Vietnam. It also evaluates the positive predictive value (PPV) of immunological criteria to detect treatment failure.
R L Murphy
Antiviral therapy, 3 Suppl 4, 69-73 (2000-03-21)
Initial studies of multiple-agent antiretroviral combinations including the thymidine nucleoside analogue reverse transcriptase inhibitor (RTI) stavudine (2',3'-didehydro-2',3'-dideoxythymidine; D4T) have shown potent anti-HIV effects in both treatment-naive and -experienced patients. A number of ongoing randomized comparative trials are assessing stavudine-based multiple
Nilza Nascimento Guimarães et al.
Expert opinion on drug safety, 9(5), 771-781 (2010-04-10)
The nucleoside reverse transcriptase inhibitors (NRTIs) are used in antiretroviral therapy worldwide for the treatment of HIV infections. These drugs act by blocking reverse transcriptase enzyme activity, causing pro-viral DNA chain termination. As a consequence, NRTIs could cause genomic instability
G Skowron
The Journal of infectious diseases, 171 Suppl 2, S113-S117 (1995-03-01)
Data on the biologic effects and safety of stavudine in patients with AIDS and AIDS-related complex represent results of two phase I trials (n = 84), another phase I study of patients with hematologic intolerance to zidovudine (n = 23)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service